Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in culture
- PMID: 6608693
- DOI: 10.1038/308365a0
Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in culture
Abstract
Mature human T lymphocytes can be separated by monoclonal antibodies OKT4 and OKT8 according to their surface phenotypes into T4+T8- and T4-T8+ subsets. From short-term experiments using bulk cultures, the helper/inducer function has been assigned to the T4+T8- subset and the cytotoxic/suppressor function to the T4-T8+ subset. Thus if T lymphocytes are separated after stimulation in a mixed lymphocyte reaction (MLR), the entire cytotoxic activity is found in the T4-T8+ fraction whereas the T4+T8- fraction shows no detectable cytotoxicity. If, however, T lymphocytes are cloned after MLR and grown in long-term culture, a surprisingly large fraction of T4+ T lymphocyte clones (TLC) shows cytotoxic activity. Here we report that T4+ TLC can acquire specific cytotoxicity during in vitro cultivation.
Similar articles
-
Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function.J Exp Med. 1984 Mar 1;159(3):921-34. doi: 10.1084/jem.159.3.921. J Exp Med. 1984. PMID: 6421984 Free PMC article.
-
Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.J Immunol. 1984 Jan;132(1):510-9. J Immunol. 1984. PMID: 6197458
-
T-cell subsets in human lymphocytes maintained in IL-2 medium after PHA or mixed lymphocyte reaction activation.Clin Immunol Immunopathol. 1983 Jun;27(3):444-51. doi: 10.1016/0090-1229(83)90096-x. Clin Immunol Immunopathol. 1983. PMID: 6223760
-
Relationship between human T cell functional heterogeneity and human T cell surface molecules.Immunol Rev. 1983;74:113-28. doi: 10.1111/j.1600-065x.1983.tb01086.x. Immunol Rev. 1983. PMID: 6226584 Review.
-
[Analysis of T-cell subpopulations. Pathophysiological concept and significance for clinical medicine].Schweiz Med Wochenschr. 1985 Apr 20;115(16):534-50. Schweiz Med Wochenschr. 1985. PMID: 3159084 Review. German.
Cited by
-
T cell targeting in cancer therapy.Cancer Immunol Immunother. 1991;34(1):1-8. doi: 10.1007/BF01741317. Cancer Immunol Immunother. 1991. PMID: 1760806 Free PMC article. Review.
-
Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets.J Exp Med. 1988 Feb 1;167(2):345-52. doi: 10.1084/jem.167.2.345. J Exp Med. 1988. PMID: 2450158 Free PMC article.
-
Human CD4+ T-Cell Clone Expansion Leads to the Expression of the Cysteine Peptidase Inhibitor Cystatin F.Int J Mol Sci. 2021 Aug 5;22(16):8408. doi: 10.3390/ijms22168408. Int J Mol Sci. 2021. PMID: 34445118 Free PMC article.
-
Antigen-specific, I-A-restricted suppressor hybridomas with spontaneous cytolytic activity. Functional properties and lack of rearrangement of the T cell receptor beta chain genes.J Exp Med. 1985 Sep 1;162(3):851-63. doi: 10.1084/jem.162.3.851. J Exp Med. 1985. PMID: 3875684 Free PMC article.
-
CD4+ Th0 cell clones, isolated from a metastatic lymph node of a melanoma patient, possess cytolytic function.Cancer Immunol Immunother. 1995 Oct;41(4):210-6. doi: 10.1007/BF01516995. Cancer Immunol Immunother. 1995. PMID: 7489563 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
